We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Prothena Corporation PLC | NASDAQ:PRTA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.16 | 13.50 | 17.00 | 0 | 00:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices, including Zip Code) |
Registrant’s telephone number, including area code:
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
Trading |
Name of Each Exchange on Which Registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02(b) | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On December 29, 2024, Oleg Nodelman notified Prothena Corporation plc (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”), effective as of December 31, 2024, to create time to focus on existing and new endeavors. Mr. Nodelman will continue to serve on the Board, the Compensation Committee of the Board, and the Nominating and Corporate Governance Committee of the Board through December 31, 2024. His decision to resign was not because of a disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 30, 2024 | PROTHENA CORPORATION PLC | |||||
By: | /s/ Tran B. Nguyen | |||||
Name: | Tran B. Nguyen | |||||
Title: | Chief Strategy Officer and Chief Financial Officer |
Document and Entity Information |
Dec. 29, 2024 |
---|---|
Cover [Abstract] | |
Entity Registrant Name | PROTHENA CORP PUBLIC LTD CO |
Amendment Flag | false |
Entity Central Index Key | 0001559053 |
Document Type | 8-K |
Document Period End Date | Dec. 29, 2024 |
Entity Incorporation State Country Code | L2 |
Entity File Number | 001-35676 |
Entity Tax Identification Number | 98-1111119 |
Entity Address, Address Line One | 77 Sir John Rogerson’s Quay |
Entity Address, Address Line Two | Block C |
Entity Address, Address Line Three | Grand Canal Docklands |
Entity Address, City or Town | Dublin 2 |
Entity Address, Postal Zip Code | D02 VK60 |
Entity Address, Country | IE |
City Area Code | 011-353-1 |
Local Phone Number | 236-2500 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Ordinary Shares, par value $0.01 per share |
Trading Symbol | PRTA |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
1 Year Prothena Chart |
1 Month Prothena Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions